QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.022608v1 70/4/1340    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quinet, E. M. Articles by Nambi, P. Search for Related Content PubMed PubMed Citation Articles by Quinet, E. M. Articles by Nambi, P.

Liver X Receptor (LXR)-β Regulation in LXR-Deficient Mice: Implications for Therapeutic Targeting

Department of Cardiovascular/Metabolic Diseases, Wyeth Research, Collegeville, Pennsylvania (E.M.Q., D.A.S., A.R.H., L.C., M.D.B., P.N.); and Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden (G.U.S., J.-Å.G.)

The nuclear receptors liver X receptor (LXR) LXR and LXRβ are differentially expressed ligand-activated transcription factors that induce genes controlling cholesterol homeostasis and lipogenesis. Synthetic ligands for both receptor subtypes activate ATP binding cassette transporter A1 (ABCA1)-mediated cholesterol metabolism, increase reverse cholesterol transport, and provide atheroprotection in mice. However, these ligands may also increase hepatic triglyceride (TG) synthesis via a sterol response element binding protein 1c (SREBP-1c)-dependent mechanism through a process reportedly regulated by LXR. We studied pan-LXR/β agonists in LXR knockout mice to assess the contribution of LXRβ to the regulation of selected target genes. In vitro dose-response studies with macrophages from LXR-/- and β-/- mice confirm an equivalent role for LXR and LXRβ in the regulation of ABCA1 and SREBP-1c gene expression. Cholesterol-efflux studies verify that LXRβ can drive apoA1-dependent cholesterol mobilization from macrophages. The in vivo role of LXRβ in liver was further evaluated by treating LXR-/- mice with a pan-LXR/β agonist. High-density lipoprotein (HDL) cholesterol increased without significant changes in plasma TG or very low density lipoprotein. Analysis of hepatic gene expression consistently revealed less activation of ABCA1 and SREBP-1c genes in the liver of LXR null animals than in treated wild-type controls. In addition, hepatic CYP7A1 and several genes involved in fatty acid/TG biosynthesis were not induced. In peripheral tissues from these LXR-null mice, LXRβ activation increases ABCA1 and SREBP-1c gene expression in a parallel manner. However, putative elevation of SREBP-1c activity in these tissues did not cause hypertriglyceridemia. In summary, selective LXRβ activation is expected to stimulate ABCA1 gene expression in macrophages, contribute to favorable HDL increases, but circumvent hepatic LXR-dominated lipogenesis.

Address correspondence to: Dr. Elaine M. Quinet, Department of Cardiovascular/Metabolic Diseases, Wyeth Research, 500 Arcola Road, RN2229, Collegeville, PA 19426. E-Mail: quinete{at}wyeth.com

This article has been cited by other articles:

				J. P. Mauldin, M. H. Nagelin, A. J. Wojcik, S. Srinivasan, M. D. Skaflen, C. R. Ayers, C. A. McNamara, and C. C. Hedrick Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus Circulation, May 27, 2008; 117(21): 2785 - 2792. [Abstract] [Full Text] [PDF]

				I. P. Torra, N. Ismaili, J. E. Feig, C.-F. Xu, C. Cavasotto, R. Pancratov, I. Rogatsky, T. A. Neubert, E. A. Fisher, and M. J. Garabedian Phosphorylation of Liver X Receptor {alpha} Selectively Regulates Target Gene Expression in Macrophages Mol. Cell. Biol., April 15, 2008; 28(8): 2626 - 2636. [Abstract] [Full Text] [PDF]

				P. Kotokorpi, E. Ellis, P. Parini, L.-M. Nilsson, S. Strom, K. R. Steffensen, J.-A. Gustafsson, and A. Mode Physiological Differences between Human and Rat Primary Hepatocytes in Response to Liver X Receptor Activation by 3-[3-[N-(2-Chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic Acid Hydrochloride (GW3965) Mol. Pharmacol., October 1, 2007; 72(4): 947 - 955. [Abstract] [Full Text] [PDF]